Literature DB >> 6174167

Combination chemotherapy for advanced bladder cancer.

R R Hall, R G Evans, C J Pritchett, D A Price.   

Abstract

Adriamycin, bleomycin, 5-fluorouracil and methotrexate have been used in combination in a Phase II study and as adjuvant chemotherapy for patients with locally advanced bladder cancer. Although early results with metastatic disease showed considerable antitumour activity, longer follow-up has shown this drug combination to be ineffective.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6174167     DOI: 10.1111/j.1464-410x.1982.tb13504.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  2 in total

1.  Adjuvant chemotherapy for invasive bladder cancer.

Authors:  Y Uekado; T Shinka; A Hirano; T Ohkawa
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

2.  Postoperative systemic adjuvant chemotherapy for bladder cancer.

Authors:  H Kiyohara; M Kuroda; S Saiki; T Miki; T Kinouchi; M Usami; T Kotake
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.